Cira, K.; Weber, M.-C.; Wilhelm, D.; Friess, H.; Reischl, S.; Neumann, P.-A.
The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 6884.
https://doi.org/10.3390/jcm11236884
AMA Style
Cira K, Weber M-C, Wilhelm D, Friess H, Reischl S, Neumann P-A.
The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2022; 11(23):6884.
https://doi.org/10.3390/jcm11236884
Chicago/Turabian Style
Cira, Kamacay, Marie-Christin Weber, Dirk Wilhelm, Helmut Friess, Stefan Reischl, and Philipp-Alexander Neumann.
2022. "The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 11, no. 23: 6884.
https://doi.org/10.3390/jcm11236884
APA Style
Cira, K., Weber, M.-C., Wilhelm, D., Friess, H., Reischl, S., & Neumann, P.-A.
(2022). The Effect of Anti-Tumor Necrosis Factor-Alpha Therapy within 12 Weeks Prior to Surgery on Postoperative Complications in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 11(23), 6884.
https://doi.org/10.3390/jcm11236884